20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Professor David K. Simon: new chair of the iLCT Committee
Cure Parkinson’s and Van Andel Institute are delighted to announce that Professor David K. Simon, of Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States has accepted the position as chair of the International Linked Clinical Trials (iLCT) Committee. This prestigious committee…
Tribute to Her Majesty The Queen
We are very saddened to hear of the death of Her Majesty Queen Elizabeth II and would like to offer our deepest condolences to The Royal Family at this time.
Cycling America’s Coast to Coast to help find a cure
Kate Osborne cycled 3,659 miles from California to North Carolina to raise funds and awareness for Parkinson’s research. When Kate was planning her epic 3,659 mile cycle, she decided that it was a great opportunity to raise some money for two charities close to her…
Questions about Parkinson’s: ask the expert
NIHR Clinical Research Network Thames Valley and South Midlands recorded a recent webinar featuring Professor Michele Hu and journalist Rory Cellan-Jones.
Phase 1 trial results of new GDNF delivery mechanism
The results of a recent clinical trial testing a new way of delivering the nerve growth factor, GDNF, into the brains of people with Parkinson’s demonstrate that it is safe and well tolerated. Glial cell-line derived neurotrophic factor, or GDNF as it is more commonly…